EvolveImmune Therapeutics

[On Demand]
Search General Info
Search Education
Search Partnering Companies
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in the Yale/New Haven biotechnology ecosystem with laboratories in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Laboratory at Yale University, EvolveImmune is leveraging a novel in vivo CRISPR-based target discovery platform to develop a broad portfolio of first-in-class biologics for unmet needs in oncology and immune diseases.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Connecticut
Company HQ Country:
United States
Year Founded:
2019
Main Therapeutic Focus:
Lead Product in Development:
EI-104
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Undisclosed
Speaker
photo
Chief Executive Officer
EvolveImmune Therapeutics, Inc.